PGIM India Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-2.16%)Nav, as on 23-03-2026

  • Previous Nav

  • Net Change on 23-03-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 -0.48 22.05 14.59 1.81 8,306.35
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 -1.44 25.55 16.44 1.86 6,801.16
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 -1.95 23.81 16.50 1.93 4,076.67
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 -5.86 20.08 13.76 1.94 3,033.42
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 1.39 23.57 15.24 1.93 2,843.74

Fund Holdings as on 28-February-2026

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Aster DM Healthcare Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Max Healthcare Institute Ltd.

  • Rubicon Research Ltd.

  • Mankind Pharma Ltd.

  • Ajanta Pharma Ltd.

  • Krishna Inst of Medical Sciences Ltd.

  • Abbott India Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Sai Life Sciences Ltd

  • Dr. Lal Path Labs Ltd.

  • Navin Fluorine International Ltd.

  • Clearing Corporation of India Ltd.

  • Neuland Laboratories Ltd.

  • Jupiter Life Line Hospitals Ltd.

  • Anthem Biosciences Ltd.

  • Global Health Ltd.

  • Cipla Ltd.

  • PB Fintech Ltd.

  • ICICI Lombard General Insurance Co. Ltd.

  • Lenskart Solutions Ltd.

  • Orchid Pharma Ltd.

  • Sagility Ltd.

  • Dr Agarwal's Eye Hospital Ltd.

  • Dr Agarwal's Health Care Ltd.

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Chemicals

  • Fintech

  • Insurance

  • Medical Equipment/Supplies/Accessories

  • Business Support

View More

Fund Manager

  • Cash

  • Equity

View More

About PGIM India Healthcare Fund

Scheme Analysis

PGIM India Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to PGIM India Mutual Fund. It was launched on 06-Dec-2024 and currently has an AUM of ₹92.45 crore. PGIM India Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of PGIM India Healthcare Fund ended down ₹-0.21(-2.16%)yesterday to ₹9.49.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The PGIM India Healthcare Fund is managed by Puneet Pal and Anandha Padmanabhan Anjeneyan.

Fund House Contact

4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 61593000
care@pgimindia.com
+91 (22) 61593100